Works matching IS 01615505 AND DT 2024 AND VI 65 AND IP 9
Results: 34
Robert Carretta, MD, 1941–2023.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1498
- Publication type:
- Article
FINDing the Future of Radiopharma.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Reply: The Potential Value of Functional Adrenal Imaging in Primary Aldosterone.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1450, doi. 10.2967/jnumed.124.267988
- By:
- Publication type:
- Article
The Potential Value of Functional Adrenal Imaging in Primary Aldosterone.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Impact of Posttreatment SPECT/CT on Patient Management During <sup>177</sup>Lu-PSMA-617 Radiopharmaceutical Therapy.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1395, doi. 10.2967/jnumed.124.267955
- By:
- Publication type:
- Article
<sup>177</sup>Lu-PSMA (R)Evolution in Cancer Care: Is It Really Happening?
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1340, doi. 10.2967/jnumed.124.267951
- By:
- Publication type:
- Article
Prostate-Specific Membrane Antigen PET/CT–Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1387, doi. 10.2967/jnumed.124.267922
- By:
- Publication type:
- Article
[<sup>68</sup>Ga]Ga-PSMA-11 PET and Prostate Cancer Bone Metastases: Diagnostic Performance of Available Standardized Criteria.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1376, doi. 10.2967/jnumed.124.267899
- By:
- Publication type:
- Article
Utility of <sup>64</sup>Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on <sup>68</sup>Ga-PSMA-11 PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1371, doi. 10.2967/jnumed.124.267881
- By:
- Publication type:
- Article
International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline <sup>18</sup>F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1343, doi. 10.2967/jnumed.124.267789
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL PSMA PET/CT Tracheobronchial Uptake in Patients with Prostate Cancer: Incidence and Etiology.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1383, doi. 10.2967/jnumed.124.267772
- By:
- Publication type:
- Article
Single Chelator–Minibody Theranostic Agents for <sup>89</sup>Zr PET Imaging and <sup>177</sup>Lu Radiopharmaceutical Therapy of PSMA-Expressing Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1435, doi. 10.2967/jnumed.124.267667
- By:
- Publication type:
- Article
Reply: Considerations Surrounding the Sentinel Lymph Node in Prostate Cancer and Unanswered Questions.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Neurologic Symptoms After <sup>177</sup>Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1402, doi. 10.2967/jnumed.124.267643
- By:
- Publication type:
- Article
Unrealistic Data Augmentation Improves the Robustness of Deep Learning–Based Classification of Dopamine Transporter SPECT Against Variability Between Sites and Between Cameras.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1463, doi. 10.2967/jnumed.124.267570
- By:
- Publication type:
- Article
<sup>211</sup>At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1443, doi. 10.2967/jnumed.124.267540
- By:
- Publication type:
- Article
[<sup>177</sup>Lu]Lu-Prostate-Specific Membrane Antigen-617 in a Patient with Metastatic Castration-Resistant Prostate Cancer and Status After Bilateral Nephrectomy.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1493, doi. 10.2967/jnumed.124.267533
- By:
- Publication type:
- Article
[<sup>177</sup>Lu]Lu-DOTATATE May Resensitize Neuroendocrine Tumors to Hormonal Therapy: Initial Clinical Experience in Renal Carcinoid.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1494, doi. 10.2967/jnumed.124.267497
- By:
- Publication type:
- Article
Development of a <sup>213</sup>Bi-Labeled Pyridyl Benzofuran for Targeted α-Therapy of Amyloid-β Aggregates.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1467, doi. 10.2967/jnumed.124.267482
- By:
- Publication type:
- Article
Considerations Surrounding the Sentinel Lymph Node in Prostate Cancer and Unanswered Questions.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Role of <sup>64</sup>CuCl<sub>2</sub> PET/CT in Detecting and Staging Muscle-Invasive Bladder Cancer: Comparison with Contrast-Enhanced CT and <sup>18</sup>F-FDG PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1357, doi. 10.2967/jnumed.124.267474
- By:
- Publication type:
- Article
Elevated Baseline Mean Corpuscular Volume Predicts the Development of Severe Hematologic Toxicity After <sup>177</sup>Lu-DOTATATE Therapy.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1423, doi. 10.2967/jnumed.124.267462
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1416, doi. 10.2967/jnumed.123.267363
- By:
- Publication type:
- Article
StepBrain: A 3-Dimensionally Printed Multicompartmental Anthropomorphic Brain Phantom to Simulate PET Activity Distributions.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1489, doi. 10.2967/jnumed.123.267277
- By:
- Publication type:
- Article
Advancing Tau PET Quantification in Alzheimer Disease with Machine Learning: Introducing THETA, a Novel Tau Summary Measure.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1473, doi. 10.2967/jnumed.123.267273
- By:
- Publication type:
- Article
<sup>61</sup>Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1427, doi. 10.2967/jnumed.123.267126
- By:
- Publication type:
- Article
This Month in JNM.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 8
- Publication type:
- Article
Total-Body Dynamic Imaging and Kinetic Modeling of [<sup>18</sup>F]F-AraG in Healthy Individuals and a Non–Small Cell Lung Cancer Patient Undergoing Anti–PD-1 Immunotherapy.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1481, doi. 10.2967/jnumed.123.267003
- By:
- Publication type:
- Article
Paraplegic Patient with Metastatic Papillary Thyroid Cancer: A Multidisciplinary Approach to Radioactive Iodine Therapy Safety and Efficacy Strategy.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1336, doi. 10.2967/jnumed.123.266955
- By:
- Publication type:
- Article
Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of <sup>225</sup>Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1456, doi. 10.2967/jnumed.123.266894
- By:
- Publication type:
- Article
Quantitative Assessments of Tumor Activity in a General Oncologic PET/CT Population: Which Metric Minimizes Tracer Uptake Time Dependence?
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1349, doi. 10.2967/jnumed.123.266469
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1409, doi. 10.2967/jnumed.123.266956
- By:
- Publication type:
- Article
Theranostic Intratumoral Convection-Enhanced Delivery of <sup>124</sup>I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1364, doi. 10.2967/jnumed.123.266365
- By:
- Publication type:
- Article